O'Shaughnessy Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.67M | Sell |
5,093
-2,128
| -29% | -$1.12M | 0.02% | 671 |
|
|
2025
Q1 | $4.58M | Buy |
7,221
+1,074
| +17% | +$681K | 0.04% | 450 |
|
|
2024
Q4 | $4.38M | Sell |
6,147
-2,634
| -30% | -$1.88M | 0.04% | 447 |
|
|
2024
Q3 | $8.91M | Buy |
8,781
+879
| +11% | +$892K | 0.08% | 270 |
|
|
2024
Q2 | $8.31M | Buy |
7,902
+982
| +14% | +$1.03M | 0.09% | 262 |
|
|
2024
Q1 | $6.66M | Buy |
6,920
+1,030
| +17% | +$991K | 0.07% | 295 |
|
|
2023
Q4 | $5.17M | Buy |
5,890
+153
| +3% | +$134K | 0.07% | 303 |
|
|
2023
Q3 | $4.72M | Buy |
5,737
+2,553
| +80% | +$2.1M | 0.07% | 296 |
|
|
2023
Q2 | $2.29M | Sell |
3,184
-203
| -6% | -$146K | 0.03% | 423 |
|
|
2023
Q1 | $2.78M | Buy |
3,387
+26
| +0.8% | +$21.4K | 0.04% | 385 |
|
|
2022
Q4 | $2.42M | Buy |
3,361
+350
| +12% | +$253K | 0.04% | 390 |
|
|
2022
Q3 | $2.07M | Buy |
3,011
+1,400
| +87% | +$964K | 0.04% | 385 |
|
|
2022
Q2 | $952K | Buy |
1,611
+309
| +24% | +$183K | 0.02% | 537 |
|
|
2022
Q1 | $909K | Buy |
1,302
+533
| +69% | +$372K | 0.02% | 554 |
|
|
2021
Q4 | $486K | Sell |
769
-48
| -6% | -$30.3K | 0.01% | 700 |
|
|
2021
Q3 | $495K | Buy |
817
+256
| +46% | +$155K | 0.01% | 651 |
|
|
2021
Q2 | $313K | Buy |
561
+36
| +7% | +$20.1K | 0.01% | 838 |
|
|
2021
Q1 | $248K | Sell |
525
-93
| -15% | -$43.9K | 0.01% | 840 |
|
|
2020
Q4 | $299K | Sell |
618
-29
| -4% | -$14K | 0.01% | 692 |
|
|
2020
Q3 | $362K | Buy |
647
+29
| +5% | +$16.2K | 0.01% | 527 |
|
|
2020
Q2 | $385K | Buy |
618
+530
| +602% | +$330K | 0.01% | 465 |
|
|
2020
Q1 | $43K | Sell |
88
-9
| -9% | -$4.4K | ﹤0.01% | 808 |
|
|
2019
Q4 | $36K | Buy |
+97
| New | +$36K | ﹤0.01% | 1027 |
|